China
· Delayed Price · Currency is CNY Jiangxi Fushine Pharmaceutical Company Description
Jiangxi Fushine Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of APIs and pharmaceutical intermediates in China and internationally.
The company offers β-lactamase inhibitors, carbapenem antibiotics, and antiviral drug intermediates; argatroban injection for the treatment of acute ischemic stroke; and doxycycline hydrochloride dispersible tablets to treat rickettsial diseases, mycoplasmal and chlamydial infections, relapsing fever, brucellosis, cholera, tularemia, plague, and chancroid.
It also provides lithium-ion battery electrolyte additives; and microbial protein, amino acid water-soluble fertilizer, and other bio-fermentation products.
The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012.
Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is headquartered in Jingdezhen, China.
| Country | China |
| Founded | 2002 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,774 |
| CEO | Jian Hua Bao |
Contact Details
Address: No. 2, Yuli Industrial Zone Jingdezhen, 333000 China | |
| Phone | 86 79 8269 9929 |
| Website | fushine.cn |
Stock Details
| Ticker Symbol | 300497 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE1000024Z7 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Jian Hua Bao | GM and Chairman |
| Guang Yang | Financial Director |
| Yun Peng | Deputy GM and Secretary of the Board of Directors |
| Xiang Ming Zhang | Deputy General Manager |
| Zhen Liang Dai | Deputy General Manager |
| Ying Liu | Deputy General Manager |
| Haipeng Wei | Deputy General Manager |
| Yinghui Chen | Deputy General Manager |
| Haiyan Xie | Accounting Supervisor |
| Wei Dong | Manager of the Sales Department and Supervisor |